Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 01/12/18
End: 04/11/19
Due: 04/11/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase II Study of AP0302 5% Versus a Vehicle Comparator | NCT02324985 | Aponia Laboratories, Inc. | user2@example.com | None | 2015-01-31 | 2016-06-30 | 2017-06-30 | - | - | 2025-07-14 |
| Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS | NCT03852459 | Aponia Laboratories, Inc. | user2@example.com | None | 2018-01-12 | 2019-04-11 | 2020-04-11 | - | - | 2025-07-14 |